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Interaction of TCRs on CD4+CD8+ immature T cell with MHC-peptide complexes on stro-
mal cells is required for positive and negative selection in the thymus. Identification and char-
acterization of a subpopulation ofCD4/CD8+ thymocytes undergoing selection in the thymus
will aid in understanding the mechanisms underlying lineage commitment and thymic selec-
tion. Herein, we describe the expression of Ly-6 ThB on developing thymocytes. The major-
ity of CD4+CD8
/ thymocytes express Ly-6 ThB at high levels. Its expression is
downregulated in a subset of CD4+CD8
/ thymocytes as well as in mature CD4/CD8 and
CD4-CD8
/ T cells. More importantly, interaction of TCR/coreceptor with the self-MHC-pep-
tide contributes to the downregulation of ThB expression on developing thymocytes. These
findings indicate that downregulation of ThB on CD4+CD8
/ thymocytes identifies a unique
+ + neg low subset (CD4 CD8 ThB of thymocytes that has received the initial signals for thymic
selection but have not yet downregulated the CD4 and CD8 cell surface expression. In addi-
tion, these results also indicate that a high frequency (~20-40%) of CD4+CD8
/ immature
thymocytes receive these initial signals during thymic selection.
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INTRODUCTION
Development of thymocytes and their selection
occurs in discreet steps in the thymus. It has become
increasingly clear that various cell surface proteins on
T lymphocytes interacting with their ligands on the
stromal cells are critical for these processes (1). A key
set of proteins involved in the thymic development is
the TCR/CD3 complex and antigen coreceptors (CD4
and CD8) (2, 3). For example, expression of
TCR-beta (pre-TCR complex) is critical for
CD4-CD8- to CD4+CD8
/ cell development (2, 3).
Expression of TCR-alpha-beta is critical for further
development into either CD4/CD8 helper T cells or
CD4-CD8
/ cytotoxic T cells (3-5). The underlying
mechanisms involved in these developmental proc-
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esses and lineage commitment to CD4+ helper or
CD8+ cytotoxic T cell are unclear. The identification
and analysis of a subset within CD4+CD8
/ thymo-
cytes that have received initial signals through their
TCR’s will aid in providing insights into the underly-
ing mechanisms for T cell selection as well as lineage
commitment.
ThB is a member of the Ly-6 multigene family
expressed on thymocytes, B cells, and keratinocytes
(6-9). Similar to other known members of the Ly-6
multigene family, ThB is 10-12 kDa in molecular
mass and linked to the cell surface by a GPI-anchor
(10, 11). Although the biological function of the ThB
molecule is unknown, recent reports indicate that the
human homologue of ThB (E48) has cell-cell adhe-
sion function in keratinocytes (9). These latter obser-
vations are consistent with the cell adhesion
properties reported for other members of the Ly-6
gene family (12-14).
A distinct feature of some Ly-6 proteins is their
regulated expression during the development of
hematopoietic cells (11, 15). For example, Ly-6A.2 is
expressed on stem cells (16, 17) as well as on the a
CD44
/ subset of CD4-CD8-CD3- T cells in the thy-
mus (18). Ly-6A.2 is absent on the the majority of
immature thymocytes including the CD4+CD8
/ sub-
set but reexpressed on mature T cells in the thymus
and spleen (19). In this regard, approximately 50-
80% of thymocytes express ThB, but expression of
this molecule at different developmental stages dring
thymic development is unknown.
Herein, we present evidence that Ly-6 ThB expres-
sion is tightly regulated during thymic development.
Interaction of antigen receptor and CD4/CD8 with
self-MHC-peptide contributes to the downregulation
of ThB on CD4+CD8
/ thymocytes. These results
indicate that ThBneg-lw CD4/CD8+ T cells are com-
posed of a subset of thymocytes that have received
initial signals through the antigen receptor and core-
ceptor but have not yet downregulated their corecep-
tor. In addition, this study also indicates that a high
frequency of developing CD4/CD8
/ thymocytes
express an antigen receptor that has bias towards
reactivity to self-MHC-peptide complexes.
RESULTS
Expression ofThB on T cell subsets
in the thymus and the periphery
We sought to examine ThB expression in BALB/c
mice for each of the four thymic subsets defined by
anti-CD4 and anti-CD8 antibodies (Figure 1A).
Approximately 40% of the CD4-CD8- subset that
comprise 2-4% of total thymocytes express high lev-
els of ThB on their surface (DN/R4). A majority of
CD4/CD8+ thymocytes (62%) expresses high levels
of ThB (DP/R2). In contrast, 93% of CD4/CD8, and
93% of CD4-CD8/thymocytes are ThBnegative-lw
(Figure 1 A&B). Similar results were obtained with a
number of strains of mice including, C57BL/6, SWR,
AKR, SJL (data not shown). One notable exception
was the higher expression of ThB as well as higher
numbers of ThB expressing thymocytes in C57BL/6
mice compared to BALB/c mice, which is consistent
with previous report (25). Approximately 80% of the
CD4/CD8+ thymocytes from C57BL/6 mice express
higher levels of ThB as compared to about 60% this
subset in BALB/c mice. Mature CD4
/ and CD8
/ T
cell subsets in the periphery (lymph node and spleen)
do not show surface expression of ThB (data not
shown) as previously described (8). These data indi-
cate that ThB expression is downregulated during
development of immature CD4+CD8
/ to mature
CD4+CD8 and CD4-CD8
/ cells. These results also
indicate regulated expression of ThB within the
CD4+CD8
/ subset of thymocytes and identify novel
ThBlw and ThBhigh subpopulations with in
CD4+CD8
/ subset.
ThB surface expression correlates
with maturational status of developing T cells
in the thymus
As T cells mature in the thymus they lose expression
of CD4 or CD8 coreceptors. To evaluate the the
expression of ThB during this process we performed
three color analysis using anti-CD4, anti-CD8 and
anti-ThB flourochrome conjugated antibodies andREGULATED EXPRESSION OF LY-6-THB 109
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FIGURE Expression of ThB on thymocytes from BALB/c mouse. Thymocytes were isolated and stained with anti-CD4-PE,
anti-CD8-FITC, anti-ThB-Biotin and streptavidin-Red as described in Materials and Methods. Each of the four subsets based on the expres-
sion of CD4 and CD8 were analyzed for the expression of ThB (A). ThB positive cells in the four thymic subsets, CD4-CD8-, CD4+CD8/,
CD4/CD8 and CD4-CD8 from six independent experiments are shown (B) (n=6). Error bars indicate standard error110 JUSTIN T. REESE et al.
gated on either DP thymocytes or CD4+ thymocytes
that have partially or completely downregulated the
CD8 coreceptor. Figure 2 shows that the expression
of ThB is lowest in CD4/CD8 T cells and intermedi-
ate in CD4+CD8lw and highest in CD4/CD8+ T cells
in the thymus. Similarly CD41WCD8
/ T cells also
expressed lower levels of ThB (Figure2) and
CD4-CD8
/ showed the lowest expression like
CD4/CD8 helper subset (data not shown). These
results strongly suggest that as thymocytes mature
and lose CD4 or CD8 coreceptors, there is a coordi-
nate loss of ThB.
Maturation of CD4+ helper and CD8+ cytotoxic T
cells from CD4/CD8+ immature T cell involves
upregulation of TCR/CD3, CD5 proteins and down-
modulation of CD4 or CD8 molecules. To further
examine the expression of ThB on developing T cells
we analyzed BALB/c thymocytes using anti-ThB and
anti-CD5 (Figure 3 A&B). Majority of the thymo-
cytes that show higher expression ofCD5 have down-
regulated ThB expression (65.1+/-8%). A subset of
thymocytes (28.3+/-12%) with higher expression of
CD5 also have high expression of ThB. These suggest
that with in CD5+ thym,ocytes both ThBhigh and
ThBlw subpopulations exist. Similar analysis using
anti-ThB and anti-CD3 antibodies indicated that
majority of CD3high (approximately 16.5%) (mature
subset) expressed lower levels of ThB. Interestingly,
about 25% of CD3neg-intermidiate (immature subset)
cells show downregulation of ThB. This analysis indi-
cates that as T cells become mature (i.e., upregulation
of CD5 and TCR) they lose ThB expression from the
cell surface. Taken together our data strongly suggests
that downregulation of ThB expression correlates
with the maturity of developing T cells in the thymus.
Regulation ofThB surface expression
by interaction of antigen receptor and co-receptor
with self-MHC-peptide complexes
The progression of CD4+CD8+ thymocytes to the
mature CD4+CD8 or CD4-CD8+ thymocytes require
ligation of the TCR and the CD4 or CD8 coreceptor.
We hypothesized that interaction of the antigen recep-
tor with self-MHC results in the downregulation of
ThB expression on CD4/CD8+ thymocytes. To exam-
ine this hypothesis we determined the expression of
ThB in the AND TCR transgenic mice that express
the transgene either on a selecting (H-2b, B10) or
non-selecting (H-2d B10.D2) background (21). The
expression of ThB was lower on thymocytes from
AND-H-2b mice than on the T cells from AND-H-2d
mice (Figure 4A). As reported previously, we also
observed a higher percentage of CD4
/ ceils in AND
transgenic mice on H-2b(Selecting) as compared to
H-2d (non.-Selecting) background (21). Further analy-
sis of the ThBneg, ThBlw and ThBhigh subsets in
AND transgenic mice on selecting and non-selecting
genetic backgrounds indicated that almost all the
ThBneg thymocytes are either CD4+ mature or
CD4CD8- immature T cells (Figure 4B). In contrast,
the majority of ThBhigh thymocytes belonged to the
CD4+CD8+ subset. Interestingly, the ThBlw thymo-
cytes included both immature CD4+CD8+ thymocytes
as well as mature CD4+and CD8
/ T cells. Moreover,
a higher percentage of ThBhigh cells were observed in
AND transgenic mice under non-selecting (24%) than
the selecting (9.7%) background. This was consistent
with observation that higher percentages of ThBlw T
cells were observed under selecting (60%) than
non-selecting (49%) backgrounds. In addition a
majority of T cells maturing under "non-selecting"
(RAG/) backgound also downregulate the expression
ofThB and therefore indicate that non-selecting back-
ground does provide weak positive slection. These
findings suggest that the expression of ThB correlates
with the positive selection of T cells in TCR trans-
genic mice and these results are consistent with what
we observe in normal non-transgenic mice (Figure 1).
We have extended our studies using several TCR
transgenic mice: (1) 5C.C7 TCR transgene (22)
expressed on selecting (B10) and non-selecting
(B10.A) genetic backgrounds (Figure 5). 2. DOll
TCR transgenic that recognizes the c-ovalbumin pep-
tide in the context of the MHC class II molecule I-Ad
(20). 3. H-Y TCR transgenic (23) female B10 mice
(data not shown). CD4
/ T cells selected in th DOll
TCR transgenic mice and CD8+ T cells selected in the
H-Y TCR transgenic female mice have down regu-
lated expression of ThB (data not shown). TakenREGULATED EXPRESSION OF LY-6-THB 111
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FIGURE 2 Expression of ThB on thymocytes with variable expression of the CD4 coreceptor. Thymocytes were isolated and stained as in
Figure and as described in Materials and Methods. Regions 1-5 were drawn based on expression of the coreceptors CD4 and CD8 indi-
cated on each panel. Expression of ThB on thymocytes in each region is shown. Numbers at the top of each panel represents percentage of
total thymocyes in the region drawn. A representative experiment of three different analyses is shown112 JUSTIN T. REESE et al.
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FIGURE 3 Expression of CD3, CD5 and ThB on thymocytes. BALB/c thymocytes were stained with anti-ThB-Biotin and either
anti-CD5-FITC (A) or anti-CD3-FITC (C), followed by strepavidin-PE. Panel B shows mean percentages +/-S.D of ceils expressing CD5
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together, our data strongly indicates that interaction of
TCR and CD4 or CD8 coreceptor with self-MHC
down regulates expression of ThB.
Expression ofThB inMHC class I and II negative
thymocytes
If the TCR/coreceptor- MHC interaction is indeed
down regulating the expression of the ThB molecule,
then preventing these interactions should also prevent
ThB down regulation. To test this hypothesis, ThB
expression on thymocytes fromMHC class III mice
was examined. In these mice there can be no interac-
tion of TCRs and CD4 on developing T cells due to
the lack of expression of MHC-peptide complexes.
Therefore, developing T cells do not get an increased
ThB expression compared with wild type C57B1/6.
These observations further substantiate the hypothesis
that the interaction of TCR/coreceptor with
self-MHC-peptide complexes is necessary to down-
regulate the cell surface expression of ThB on
CD4/CD8
/ thymocytes.
Downregulation of ,ThB expression on thymocytes
fromMHC class I’II" mice injected with anti-CD3
and anti-CD4 antibodies
Our data indicates that engagement of the TCR/core-
ceptor is necessary for the down regulation of ThB
expession. To determine if the ThB expression can be
experimenfly downregulated by engagement of both
the TCR and the coreceptor we injected anti-CD3
along with anti-CD4 antibodies in mice that lack the
expression ofMHC class I and II molecules. Thymo-
cytes from the MHC class I-II- mice are blocked in
their development at the CD4+CD8+ cell stage and
the majority show high cell surface expression of
ThB. Analysis of the thymus on day 6 post injection
revealed the presence of a subset of cells with low
ThB (Figure 7A). The downregulation of ThB was
specific because expression ofHSA was not altered in
these mice (Figure 7B). This expression is not altered
in MHC-deficeint mice injected with saline (controls)
(Figure 7A) as well as anti-CD4 + isotype control
antibody (data not shown). Moreover the downmodu-
lation of ThB was not observed on day 2 after the
injection of anti-CD3 + anti-CD4 antibody (data not
shown). Injection of antibody did not alter the cell
numbers recovered from the thymus (8.6x107 in
saline injected Vs lxl08in anti-CD3+anti-CD4
injected mice), therefore indicating that anti-CD3 and
anti-CD4 antibodies did not induce cell death in ThB-
high subset (Figure 7A). These results suggests that
ligation of TCR and CD4 proteins is required for
downregulation of ThB expression.
DISCUSSION
An interesting feature of the products of the Ly-6
locus is their regulated expression during develop-
.ment (11, 26). Ly-6A.2, one of the better-studied
members of this gene family, shows tightly regulated
expression during thymic development. Dysregulat-
ing the expression of Ly-6A.2 on T cells in the thy-
mus induces a block in development at the CD4-CD8-
cell stage, where normal expression of Ly-6A.2 is lost
(18). These observations indicate that regulated
expression of Ly-6A.2 is important for normal T cell
development (18). The data in this report indicates
that ThB also shows regulated expression on develop-
ing T cells in the thymus that is distinct and regulated
at different stages of thymic development than
Ly-6A.2. High ThB expression is observed on some
CD4-CD8-, on the majority of CD4/CD8+ thymo-
cytes and its expression is lost on mature CD4+CD8
and CD4-CD8
/ T cells. Similarly, lower expression of
ThB also correlates with the maturity of developing T
cells in the thymus as defined by CD3 and CD5
expression. Interestingly, the expression of CD5 on
CD4/CD8+ thymocytes is not biphasic (27) where as
expression of ThB does dissect CD4+CD8+ subset
into two subsets (Figure 1). These results indicate that
ThB is a unique cell surface marker on developing T
cells whose expression further dissects the CD5
expressing developing T cells in the thymus.
Study of the expression of CD44 and CD25 has
defined stages in the development of the CD4-CD8-
(DN) subset of thymocytes. Unlike the DN subset,
markers for the progression of development within
the DP subset are limited. Previous studies have sug-114 JUSTIN T. REESE et al.
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FIGURE 4 Expression of ThB on AND TCR transgenic thymocytes. Thymocytes were isolated and stained with anti-CD4-PE,
anti-CD8-FITC, anti-ThB-Biotin followed by streptavidin-Red as described in Materials and Methods. (A) CD4 and CD8 expression on total
thymocytes (gated by forward and side scatter) are shown (Upper two panels). Number in the upper left quadrant represents indicate percent-
ages of the thymic subset. Expression of ThB and CD4 (Middle two panels) and ThB and CD8 (lower two panels) is shown. (B) Analysis of
ThBhigh, ThBlow and ThBneg expression on thymocytes from AND TCR transgenic mice. Thymocytes were stained in (A) with
anti-CD4-PE, anti-CD8-FITC and anti-ThB-Biotin followed by strepavidin-red 670 were regioned based on the expression of ThB (upper
panel). ThBhigh, ThBlow and ThBneg thymocytes were analysed for the expression of CD4 and CD8 molecules (middle and lower panels).
All data are representative of two experiments116 JUSTIN T. REESE et al.
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FIGURE 5 Expression of ThB on 5C.C7 TCR transgenic thymocytes. The thymocytes were isolated from non-selective (B 10.A) and selec-
tive (B 10) MHC background mice and stained with anti-CD4-PE, anti-CD8-FITC and anti-ThB-biotin followed by strepavidin-red670. CD4
and CD8 expression on total thymocytes (gated by forward and side scatter) are shown (Upper two panels). Number in the upper left quad-
rant represents indicate percentages of the thymic subset. Expression of ThB and CD4 (Middle two panels) and ThB and CD8 (lower two
panels) is shown. All data are representative of two experimentsREGULATED EXPRESSION OF LY-6-THB 117
gested that the expression of CD3, HSA and CD69
can define the differentiation stage of thymocytes
within the DP subset. DP CD3hi thymocytes are
thought to arise from DP CD3int thymocytes (28).
HSA is highly expressed on the majority of DP thy-
mocytes and is down regulated in the majority of
mature T cells in the medulla (29). Moreover, up reg-
ulation of CD69 seems to correlate with the matura-
tion of DP thymocytes to the SP cell stage (30). Only
10% of CD4+CD8
/ thymocytes upregulate CD69 and
audition for T-cell antigen receptor mediated positive
selection (30, 31). The level of ThB can be used to
further dissect this subset of thymocytes. Therefore
ThB expression defines unique subset with in the T
cell subset (CD4/CD8+) in the thymus of normal
mice known to undergo thymic selection. Isolation
and characterization of this subset will provide further
insights into T cell development in the thymus.
Although it is noteworthy that the expression of a
number of Ly-6 molecules fluctuate during T cell
development in the thymus, how this regulation
occurs is unknown. Here we describe, that one factor
which contributes to the regulation of Ly-6 ThB is
interaction of TCR/coreceptor with self
MHC + peptide. The experimental evidence support-
ing this conclusion are: First, lower expression of
ThB expression on thymocytes from TCR transgenic
mice expressed on selecting than the non-selecting
MHC background. This decrease in ThB expression
was observed on CD4+CD8
/ thymic subset. Second,
in MHC mutant mice, in which MHC interactions
with TCR are essentially absent, ThB expression
remained high on thymocytes. 3. Injection of a com-
bination of anti-CD3 and anti-CD4 antibodies
(Figure 7) in MHC-deficient mice resulted in down-
modulation of ThB on thymocytes. 4. Endogenous
expression of ThB in wild type mice correlates with
the maturation of developing T cells in the thymus.
These results suggest that antigen receptor and core-
ceptor ligation is necessary for downmodulation of
ThB. It is possible that additional proteins expressed
on CD4/CD8
/ T cells including ThB as well as other
cell-autonomous mechanisms may also contribute to
the downmodulation of ThB.
Previous studies indicate that addition of
anti-CD3 and anti-CD4 antibodies to fetal thymi
from MHC class I-II- mice results in maturation of
CD4+ T cells and downregulates the expression of
HSA from HSAlaigh to HSAlw therefore suggesting
that these cells have undergone positive selection. In
contrast, our studies in which anti-CD3 and anti-CD4
antibodies are injected in vivo does not result in matu-
ration of CD4
/ helper T cells. Moreover, the expres-
sion of HSA also remains unaltered in these injected
mice. These different results may be attributed to the
different experimental systems used (i.e. fetal thymic
organ culture Vs injection into the mice) or differ-
ences in the amount of antibodies reaching thymo-
cytes under these different experimental conditions.
.Interestingly, injection of anti-CD3 and anti-CD4
antibodies in MHC class I-II- mice cause downregula-
tion of ThB expression on CD4+CD8+ thymocytes.
These later observations may suggest that
anti-CD3+anti-CD4 antibodies do not provide suffi-
cient ligation for full positive selection to proceed but
may initiate some initial events in this process (i.e.
downregulation of ThB expression). These later
results are consistent with other data that downregula-
tion ofThB requires interaction ofTCR and co-recep-
tor with their ligand.
Previously published data have demonstrated two
patterns of ThB expression (25). Thymocytes from
C57BL/6 mice show higher ThB expression, in com-
parison with thymocytes from BALB/c mice which
are known to show lower levels of ThB. Our observa-
tions are consistent with these published results since
only about 80% of CD4/CD8
/ thymocytes express
high levels of ThB in C57BL/6 mice as compared to
50-60% in BALB/c mouse. These differences do not
arise from expression of different alleles in these two
mouse strains (32). The genetic basis of these differ-
ences is not known. The genetic variation of ThB
expression has not been mapped to H-2 locus and
therefore lack of I-E expression in C57BL/6 is
unlikely to influence ThB expression (6). These
results suggest that ligation of TCR and CD4 mole-
cules are one of many factors that may contribute to
downregulation of ThB expression. Contribution of118 JUSTIN T. REESE et al.
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FIGURE 6 Expression ofThB onMHC class I-II-thymocytes. Thymocytes were isolated and stained with anti-CD4-PE, anti-CD8-FITC and
anti-ThB-Biotin followed by streptavidin-Red as described in Materials and Methods. ThB expression on double positive (DP) thymocytes
was determined by gating on DP thymocytes and measuring streptavidin-Red fluorescence. These data are representative of three experi-
ments
additional cell surface proteins is possible but yet
undetermined.
The CD4+CD8
/ subset of thymocytes represents a
critical stage whereMHC restriction, lineage commit-
ment and thymic selection occur. The underlying
mechanisms for these processes are largely unknown.
Identification of the transition phases within the
CD4/CD8+ subset that are dependent on the interac-
tion of TCR/coreceptor with MHC may aid in the iso-
lation and analysis of cells auditioning for thymic
selection. Our results also indicate that this interaction
regulates the expression of ThB at the DP cell stage
and we are able to identify a unique
CD4+CD8+ThBlw subset in the thymus. The
CD4+CD8+ThBlw cells constitute about 20-40% of
the total thymocyte pool. Based on the data from
non-transgenic, TCR-transgenic and MHC null mice,
CD4+CD8+ThBlw cells seems to have received ini-
tial signals of thymic selection. Our results are unable
to determine whether CD4/CD8+ thymocytes down-
regulating expression of Ly-6-ThB are undergoing or
destined to be negatively or positively selected. Given
previous reports that all the superantigen-reactive
TCR-Vf5 beating T cells are included and present in
the CD4+CD8
/ subset but absent in the mature CD4+
or CD8
/ subsets (33) suggests that downmodulation
ofThB occurs prior to disappearance of cells by nega-
tive selection and may be the result of first and initial
interaction of TCR/coreceptor with self-MHC+pep-
tide as previously proposed (34).
This data also suggests that a.high percentage of
DP thymocytes that have rearranged their TCR react
with self-MHC-peptide complexes that results in
downmodulation ofThB expression. These results are
consistent with other recent observations that T cell
repertoire that exists prior to thymic selection is
highly biased in its reactivity toMHC molecules (35-
37). The data presented in here are consistent with our
previous estimates that indicate that this reactivity is
atleast in the range of 10-15% (35). In addition,REGULATED EXPRESSION OF LY-6-THB 119
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FIGURE 7 Effect of anti-CD3 and anti-CD4 mAb’s on ThB and HSA expression in vivo. MHC class I-II- mice were injected with either
saline or anti-CD3 (145-2Cll) + anti-CD4 (GK1.5). Thymocytes from injected mice were stained six days post injection with anti-CD4-PE,
anti-CD8-FITC and anti-ThB-Biotin followed by strepavidin-red670. CD4+CD8+ T cells were gated and analyzed for the expression ofThB
(A). Expression ofHSA was also analyzed on the thymocytes from saline (solid line) and anti-CD3 + anti-CD4 (dotted line) injected mice120 JUSTIN T. REESE et al.
TCR-alpha gene loci are reported to undergo second-
ary gene rearrangement that would increase the possi-
bility of generating TCRs with reactivity to self-MHC
and peptide complexes (38).
The biological significance of downregulation of
ThB is unclear. Considering the expression pattern of
ThB (this manuscript) and adhesion properties of
human homologue of ThB (E48) (9) as well as other
Ly-6 proteins (12-14), we hypothesize that one of the
functions of ThB is to hold thymocytes in the appro-
priate thymic region where thymic selection occurs.
Therefore, downregulation of ThB will aid in
de-adhesion and movement of maturing T cells
towards the medulla. Alternatively it is also possible
that ThB participates in positive or negative selection
which might alter signaling threshold on T cells
undergoing selection. This possibility is consistent
with signaling property of Ly-6 proteins (11). The
generation of ThB transgenic mice and null mutants
will provide better insight into this phenomenon.
MATERIALS AND METHODS
Mice
BALB/c, C57B1/6, AKR, SWR, SJL, DO.11 TCR
transgenic (20) (generous gift from Dr. Dennis Lo),
AND TCR transgenic (21), 5C.C7 TCR transgenic
(22) and H-Y transgenic (23) (generously provided by
Dr. Polly Matzinger), MHC class I- and II- mice (4)
(generously provided by Dr. Lauri Glimcher) were
used in this study. Mice were bred at the University of
Georgia animal facility and used between the ages of
4-10 weeks for the experiments.
Cell Preparations and Immunofluorescence
Cell were prepared from lymphoid organs (thymus,
spleen) and stained with fluorochrome conjugated
antibodies according to previously published proto-
cols (24). Briefly, cells were stained with conjugated
antibodies, phycoerythrin (PE) anti-CD4 antibody
(H129.19), fluoroscein isothiocyanate (FITC)
anti-CD8, biotin- anti-ThB (49-H4) followed by
Streptavidin-Red 613TM (Gibco-BRL). In some
experiments thymocytes and splenocytes were stained
with 145-2Cll (anti-CD3), 53.9.2 (anti-ThB) fol-
lowed by goat anti-rat IgG-FITC. Cells were fixed
with paraformaldehyde (1% final concentration)
before analysis by cytoflourometery (Coulter Epics
Elite).
In vivo modulation ofThB expression
Purified anti-CD3 (145-2Cll), anti-CD4 (GK1.5),
Hamster IgG (9-A2A4) (50 ug/each) or saline was
injected intraperitoneally in 4-8 week oldMHC class
I-II- mice in a volume of 100 ul. The mice were sacri-
fied 2-6 days post injection and cellularity of the thy-
mus was determined followed by analysis by
immunofluorescence and flow cytometery.
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